Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.

Nason, Ian; Stein, Dorit T; Frank, Richard G; Stein, Murray B

Nason, Ian; Stein, Dorit T; Frank, Richard G; Stein, Murray B.

Afiliação

Nason I; Ian Nason (nason@g.harvard.edu) is a PhD candidate in the Department of Health Care Policy, Harvard Medical School, in Boston, Massachusetts.
Stein DT; Dorit T. Stein is an incoming PhD student in the Department of Global Health and Population, Harvard T. H. Chan School of Public Health,in Boston, Massachusetts.
Frank RG; Richard G. Frank is the Margaret T. Morris Professor of Health Economics in the Department of Health Care Policy, Harvard Medical School.
Stein MB; Murray B. Stein is Distinguished Professor of Psychiatry and Public Health, University of California San Diego, in La Jolla, California.

Health Aff (Millwood) ; 40(6): 904-909, 2021 06.

Article em En | MEDLINE | ID: mdl-34097524

ABSTRACT

ABSTRACT

COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19.

Assuntos

Antipsicóticos; COVID-19; Transtornos Mentais; Antipsicóticos/uso terapêutico; Humanos; Transtornos Mentais/tratamento farmacológico; Transtornos Mentais/epidemiologia; Pandemias; Psicotrópicos/uso terapêutico; SARS-CoV-2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / COVID-19 / Transtornos Mentais Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Health Aff (Millwood) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google